- Home
- PMAX vs LTRN Comparison
PMAX vs LTRN Comparison
Compare PMAX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMAX | LTRN |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 49.9M |
| IPO Year | 2024 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PMAX | LTRN |
|---|---|---|
| Price | $2.62 | $3.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 1.7M | 71.4K |
| Earning Date | 09-23-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,799,100.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.56 | $2.55 |
| 52 Week High | $25.12 | $6.12 |
Technical Indicators
Market Signals| Indicator | PMAX | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 47.80 |
| Support Level | $2.54 | $3.72 |
| Resistance Level | $2.97 | $3.98 |
| Average True Range (ATR) | 0.34 | 0.27 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 59.22 | 48.72 |
Price Performance
Historical ComparisonAbout PMAX Powell Max Limited
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.